产品
编 号:F487665
分子式:C24H19FN2O3
分子量:402.42
产品类型
结构图
CAS No: 866460-33-5
联系客服
产品详情
生物活性:
Setipiprant (ACT-129968) is an orally active and selective CRTH2 antagonist. Setipiprant interacts with hCRTH2 receptor with an IC50 value of 6 nM. Setipiprant inhibits prostanoid receptors hDP1 and hEP2 with IC50 values of 1290 and 2600 nM, respectively. Setipiprant can be used for the research of asthma and rhinitis.
体内研究:
1.19Pharmacokinetic Properties of Setipiprant in Rats and Dogs. AUC0-last (ng?h/mL)CL (mL/min/kg) T1/2 (hr) F (%)
RatsIV 2 mg/kg585001.3644
DogsPO 10 mg/kg9110055
体外研究:
Setipiprant (0-10 μM; 90 min) interacts with hCRTH2 receptor in the absence and presence ofHuman Serum Albumin (HSA) in the assay buffer with IC50 values of 6 and 340 nM, respectively.Setipiprant (0-10 μM; 5-20 min) inhibits hCRTH2 receptor based intracellular calcium liberation, intracellular cAMP and shape change of human eosinophils with IC50 values of 30, 80 and 235 nM, respectively.Setipiprant (0-10 μM) inhibits prostanoid receptors hDP1, hEP2 and hEP4 with IC50 values of 1290, 2600 and >10000 nM, respectively.